Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rau

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cell Reports|October 16, 2021
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBDJohn M Errico, Haiyan Zhao, Rita E Chen, et al.
Magnetic Resonance in Chemistry : MRC|August 8, 2023
Removing acoustic ringing baseline curvature in <sup>13</sup> C NMR spectra for quantitative analysesJoseph K Vasquez, Zhe Zhou, Brian Clark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2017
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapyM Friedlander, J Rau, C K Lee, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Nature Communications|March 30, 2024
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Parkinsonism & Related Disorders|July 2, 2019
Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trialK Knudsen, P Krack, L Tonder, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Survival time in cystinosis. A collaborative studyN Gretz, F Manz, R Augustin, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Mayo Clinic Proceedings|May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic ModelRaymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cell Reports|October 16, 2021
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBDJohn M Errico, Haiyan Zhao, Rita E Chen, et al.
Magnetic Resonance in Chemistry : MRC|August 8, 2023
Removing acoustic ringing baseline curvature in <sup>13</sup> C NMR spectra for quantitative analysesJoseph K Vasquez, Zhe Zhou, Brian Clark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2017
Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapyM Friedlander, J Rau, C K Lee, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Nature Communications|March 30, 2024
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Parkinsonism & Related Disorders|July 2, 2019
Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trialK Knudsen, P Krack, L Tonder, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Survival time in cystinosis. A collaborative studyN Gretz, F Manz, R Augustin, et al.
The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.
Mayo Clinic Proceedings|May 7, 2021
A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic ModelRaymund R Razonable, Nicole C E Aloia, Ryan J Anderson, et al.
Pageof 9